Clinical Trials Browser

HMPL-013 × Tumor-Agnostic × Clear all

NCT01645215 2020-02-17

Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms